Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
By C. Lawton. 2010
1,102 citations recorded by the source corpus.
Subfields: Hepatology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/cb3813d07aa68907a4bdac0e08d37dc6f0ccc4d3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
- A. Heidenreich
- Michel Bolla
- N. Mottet
- Timothy Triche
- J. Bellmunt
- V. Matveev
- Steven Joniau
- F. Zattoni
Citations in the corpus
- EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. (2011, background): “The updated results of the Southwest Oncology Group 8794 trial [69] with a median follow-up of 11.”
- EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. (2014, background): “The updated results of the SWOG 8794 trial [88] with a median follow-up of 11.”
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy (2013, background): “Recent clinical trials suggest that these patients would likely have more favorable outcomes if treated earlier post-RP [6–10].”
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, background): “Adjuvant RT (ART) was associated with improved biochemical PFS in three RCTs [126 – 128], although only SWOG 8794 suggested improved OS [128].”